The SocietyMore than 35,000 clinicians, scientists and allied health professionals from over 160 countries are part of the ERS communityBecome an ERS member
The PERSPECTIVE (Pan-European Patient-centred Network Platform for the Extraction of Valid Real-World Evidence in Thoracic Oncology) clinical research collaboration was launched by the European Respiratory Society (ERS) in 2021. Lung cancer has led the 2019 overall cancer statistics in terms of incidence and mortality rates. Within Europe, lung cancer continues to be the third most common cancer and the leading cause of cancer death. In addition, lung cancer puts the highest costs on national health systems in the European Union (EU) among all malignancies. Over the last decade, new promising developments have revolutionised the impact of diagnostics and therapies in lung cancer. Yet, the capability to manage large, multicentric data sets of different sources and formats as well as to ensure a patient-centred perspective will determine the future success of research in thoracic oncology. PERSPECTIVE has the overarching objective to set up a patient-centred network platform for research in thoracic oncology based on real-world evidence to facilitate research in the field. The creation and implementation of the envisioned powerful platform will provide a unique opportunity to impact new multicentric and multinational research and will provide valuable new insights.
To achieve those aims, five work packages have been composed:
The CRC PERSPECTIVE is composed of the following regulatory and advisory bodies:
If you are interested in more information about PERSPECTIVE net or would like to join the network, please contact firstname.lastname@example.org.